Drugs / SHEN211
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06214858 | Dec 2023 → Apr 2024 | — | JKT Biopharma Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SHEN211 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06214858 ↗ |
| Route | Oral | “was administered orally” NCT06214858 ↗ |